Analyses of Elaeocarpus sphaericus Extract for Antioxidant, Antiproliferative and Gene Repression Activities against HIF-1α and VEGF.


Journal

Chemistry & biodiversity
ISSN: 1612-1880
Titre abrégé: Chem Biodivers
Pays: Switzerland
ID NLM: 101197449

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 20 02 2023
accepted: 15 06 2023
medline: 24 8 2023
pubmed: 15 6 2023
entrez: 15 6 2023
Statut: ppublish

Résumé

The study presents antioxidant, phytochemical, anti-proliferative, and gene repression activities against Hypoxia-inducible factor (HIF-1) alpha and Vascular endothelial growth factor (VEGF) of Elaeocarpus sphaericus extract. Elaeocarpus sphaericus dried and crushed plant leaves were extracted using water and methanol by ASE (Accelerated Solvent Extraction) method. Total phenolic content (TPC) and total flavonoid content (TFC) were used to measure the extracts' phytochemical activity (TFC). Antioxidant potential of the extracts was measured through DPPH, ABTS, FRAP, and TRP. Methanolic extract of the leaves of E. sphaericus has shown a higher amount of TPC (94.666±4.040 mg/gm GAE) and TFC value (172.33±3.21 mg/gm RE). The antioxidant properties of extracts in the yeast model (Drug Rescue assay) showed promising results. Ascorbic acid, gallic acid, hesperidin, and quercetin were found in the aqueous and methanolic extracts of E. sphaericus at varying amounts, according to a densiometric chromatogram generated by HPTLC analysis. Methanolic extract of E. sphaericus (10 mg/ml) has shown good antimicrobial potential against all bacterial strains used in the study except E. coli. The anticancer activity of the extract in HeLa cell lines ranged from 77.94±1.03 % to 66.85±1.95 %, while it ranged from 52.83±2.57 % to 5.44 % in Vero cell lines at varying concentration (1000 μg/ml-31.2 μg/ml). A promising effect of extract was observed on the expression activity of HIF-1 and VEGF gene through RT-PCR assay.

Identifiants

pubmed: 37318911
doi: 10.1002/cbdv.202300249
doi:

Substances chimiques

Antioxidants 0
Vascular Endothelial Growth Factor A 0
Plant Extracts 0
Flavonoids 0
Methanol Y4S76JWI15
Phenols 0
Phytochemicals 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202300249

Subventions

Organisme : Director DIPAS, DRDO, Delhi
Organisme : Department of Biotechnology, Graphic Era Deemed to be University, Dehradun

Informations de copyright

© 2023 Wiley-VHCA AG, Zurich, Switzerland.

Références

E. Birben, U. M. Sahiner, C. Sackesen, S. Erzurum, O. Kalayci, World Allergy Organ. J. 2012, 5, 9-19. https://doi.org/10.1097/WOX.0b013e3182439613.
WHO Report: World cancer report, Edited by Bernard W. Stewart and Christopher P. Wild, 2014 IARC Publication.
A. Morales-Sanchez, Viruses 2014, 6, 4047-4079. doi: 10.3390/v6104047.
A. Giaccia, B. G. Slim, Nat. Rev. Drug Discovery 2003, 2, 803-811. https://doi.org/10.1038/nrd1199.
S. Patiar, A. L. Harris, Endocr.-Relat. Cancer 2006, 13, S61-S75. https://doi.org/10.1677/erc.1.01290.
J. A. Forsythe, B. H. Jiang, N. V. Iyer, F. Agani, S. W. Leung, R. D. Koos, G. L. Semenza, Mol. Cell. Biol. 1996, 16, 4604-4613. DOI: 10.1128/MCB.16.9.4604.
S. M. Sagar, D. Yance, R. K. Wong, Current Oncology. 2006, 13, 14-26. https://doi.org/10.3747/co.v13i1.77.
A. L. Demain, P. Vaishnav, Microb. Biotechnol. 2010, 4, 687-699. 10.1111/j.1751-7915.2010.00221.x.
R. K. Singh, G. Nath, Phytother. Res. 1999, 13, 448-450. DOI: 10.1002/(sici)1099-1573(199908/09)13, 5<448::aid-ptr480>3.0.co;2-6.
R. K. Singh, S. B. Acharya, S. K. Bhattacharya, Phytother. Res. 2000, 14, 36-39. DOI: 10.1002/(sici)1099-1573(200002)14, 1<36::aid-ptr541>3.0.co;2-j.
A. R. Juvear, S. S. Sakat, S. S. Wankhede, V. R. Mali, S. L. Bodhankar, Int. J. PharmTech Res. 2009, 1, 779-982. http://www.sphinxsai.com/PTVOL3/PT=59.
G. Shah, S. Richa, M. Avninder, R. Sandeep, P. Vivek, Int. J. PharmTech Res. 2010, 2, 1781-1786.
B. Singh, A. Chopra, T. Raj, Indian J. Pharm. Sci. 2010, 72, 261-265. DOI:10.4103/0250-474X.65021.
K. V. B. Rao, G. Kumar, L. Karthik, Bio. Tech. 2011, 40, 5384-5387.
S. E. Sudradjat, K. Herawan Timotius, Phytomedicine Plus 2022, 2 (4), 100365, https://doi.org/10.1016/j.phyplu.2022.100365.
A. B. Mahajanakatti, T. S. Deepak, R. R. Achar, S. Pradeep, S. K. Prasad, R. Narayanappa, D. Bhaskar, S. Shetty, G. Melappa, L. Chandramouli, S. Mazumdar, E. Silina, V. Stupin, C. Srinivasa, C. Shivamallu, S. P. Kollur, Molecules 2022, 27, 2442. https://doi.org/10.3390/molecules27082442.
A. Dasgupta, S. S. Agarwal, D. K. Basu, Indian J. Physiol. Pharmacol. 1984, 28, 245-246. PMID: 6519771.
T. S. Kumar, S. Shanmugam, T. Palvannam, V. V. Bharathi Kumar, IJPR 2008, 7, 211-215. 10.22037/IJPR.2010.767.
B. Singh, M. P. S. Ishar, J. Pharmacogn. Phytochem. 2013, 1, 117-121.
J. Lu, K. Zhang, S. Chen, W. Wen, Carcinogenesis 2009, 30, 636-644. doi: 10.1093/carcin/bgp009.
P. Karna, S. Chagani, S. R. Gundala, P. C. Rida, G. Asif, V. Sharma, M. V. Gupta, R. Aneja, Br. J. Nutr. 2012, 107, 473-484. DOI: 10.1017/S0007114511003308.
E. Solowey, M. Lichtenstein, S. Sallon, H. Paavilainen, E. Solowey, H. Lorberboum-Galski, TheScientificWorld 2014, 2014, 1-12. https://doi.org/10.1155/2014/721402.
H. Wagner, G. Ulrich-Merzenich, Science Direct 2008, 16, 97-110. DOI: 10.1016/j.phymed.2008.12.018.
P. Rasoanaivo, C. W. Wright, M. L. Willcox, B. Gilber, Malar. J. 2011, 10, 1-33. https://doi.org/10.1186/1475-2875-10-S1-S4.
B. Pandey, M. Rajbhandari, Nepal J. Sci. Technol. 2014, 15, 53-60. DOI:10.3126/njst.v15i1.12010.
B. C. Nandy, S. Hardainiyan, R. Saxena, Int. J. Pharm. Sci. Rev. Res. 2015, 7, 415-418. https://innovareacademics.in/journals/index.php/ijpps/article/view/5113.
A. V. A. David, R. Arulmoli, S. Parsuraman, Pharmacogn. Rev. 2016, 10, 84-89. doi: 10.4103/0973-7847.194044.
J. Dai, R. J. Mumper, Molecules 2010, 15, 7313-7352. doi: 10.3390/molecules15107313.
P. Lakhanpal, D. K. Rai, I. J. M. U 2007, 2, 20-35. DOI: 10.4314/ijmu.v2i2.39851.
M. K. Walingo, AJFAND 2005, 5, 1-13. DOI: 10.18697/ajfand.8.1155.
A. Lupulescu, Int. J. Vitam. Nutr. Res. 1994, 64, 3-14.
S. Verma, A. Singh, A. Mishra, Environ. Toxicol. Pharmacol. 2013, 35, 473-485. https://doi.org/10.1016/j.etap.2013.02.011.
A. Ahmadi, S. J. Hosseinimehr, F. Naghshvar, E. Hajir, M. Ghahremani, Arch. Pharmacal Res. 2008, 31, 794-797. https://doi.org/10.1007/s12272-001-1228-z.
N. S. M. B. A. Nayeem, H. Salem, S. Ahel-Alfqy, J. Appl. Pharmacol. 2016, 8, 1-4. DOI: 10.4172/1920-4159.1000213.
H. Parhiz, A. Roohbakhsh, F. Soltani, R. Rezaee, M. Iranshahi, Phytother. Res. 2015, 9, 323-331. https://doi.org/10.1002/ptr.5256.
R. Bos, H. Zhong, C. F. Hanrahan, E. C. Mommers, G. L. Semenza, H. M. Pinedo, M. D. Abeloff, J. W. Simons, P. J. Van Diest, E. Van der Wall, J. Natl. Cancer Inst. 2000, 93, 309-314. https://doi.org/10.1093/jnci/93.4.309.
A. Sharma, S. Joshi, N. Kumar, IJGP 2015, 9, 246-251. DOI: https://doi.org/10.22377/ijgp.v9i4.570.
A. L. Harris, Nat. Rev. Cancer 2002, 2, 38-47. DOI: 10.1038/nrc704.
G. L. Semenza, Nat. Rev. Cancer 2003, 3, 721-732. DOI: 10.1038/nrc1187.
S. J. Welsh, J. Powis, Curr. Cancer Drug Targets 2003, 3, 391-405. DOI: 10.2174/1568009033481732.
A. Hoeben, B. Landuyt, M. S. Highley, H. Wildiers, A. V. Van Oosterom, E. A. De Bruijn, Pharmacol. Rev. 2004, 56, 549-580. DOI: 10.1124/pr.56.4.3.
G. Powis, G. L. Kirkpatrick, Mol. Cancer Ther. 2004, 3, 647-654. https://doi.org/10.1158/1535-7163.647.3.5.
D. G. Nagle, Y. D. Zhou, Curr. Drug Targets 2006, 7, 355-369. doi: 10.2174/138945006776054979.
K. Yamaji, H. Ishimoto, N. Usui, S. Mori, Mycorrhiza 2005, 15, 17-23. DOI: 10.1007/s00572-003-0287-9.
H. L. L. Nang, C. Y. May, M. A. Ngan, C. C. Hock, Am. J. Environ. Sci. 2007, 3, 54-59. https://doi.org/10.3844/ajessp.2007.54.59.
K. W. Wahle, I. Brown, D. Rotondo, S. D. Heys, Adv. Exp. Med. Biol. 2010, 698, 36-51. DOI: 10.1007/978-1-4419-7347-4 4.
B. Awan, Int. Res. J. Pharm. 2013, 4, 186-188. DOI:10.7897/2230-8407.04339.
V. L. Singleton, J. A. Rossi, Am. J. Enol. Vitic. 1965, 16, 144-158.
S. Mamta, Mehrotra, V. Kirar Amitabh, P. Vats, S. P. Nandi, P. S. Negi, K. Mishra, Indian J. Exp. Biol. 2015, 53, 36-43. http://nopr.niscpr.res.in/handle/123456789/3027.
 
S. T. Chang, J. H. Wu, S. Y. Wang, P. L. Kang, N. S. Yang, L. F. Shyur, J. Agric. Food Chem. 2001, 49, 3420-3424 ;
T. C. Lin, K. H. Yu, C. M. Yang, C. C. Lin, Biol. Pharm. Bull. 2003, 26, 1331-1335. DOI: 10.1248/bpb.26.1331.
K. Thaipong, U. Boonprakoba, K. Crosbyb, L. Cisneros-Zevallosc, D. Hawkins Byrnec, J. Food Compos. Anal. 2006, 19, 669-675. DOI:10.1016/j.jfca.2006.01.003.
P. Jayanthi, P. Lalitha, Int. J. Pharm. Pharmaceut. Sci. 2011, 3 (3), 2011.
U. Golla, S. S. R. Bhimathati, The Scientific World Journal 2014, 2014, 1-8. doi: 10.1155/2014/215084.
C. Perez, M. Pauli, P. Bazerque, Arch. Biol. Med. Exp. 1990, 15, 113-115.
Y. T. Zheng, W. L. Chan, P. Chan, H. Huang, S. C. Tamm, FEBS Lett. 2001, 496, 139-142. DOI: 10.1016/s0014-5793(01)02391-2.
N. Kumar, R. C. Meena, A. Chakrabarti, Indian J. Microbiol. 2001, 512, 06-211. DOI: 10.1007/s12088-011-0132-3.
J. S. Leeuwen, N. P. E. Vermeulen, J. Vos, Curr. Drug Metab. 2012, 13, 1464-1475. DOI: 10.2174/138920012803762783.

Auteurs

Swati Joshi (S)

Department of Biotechnology, Graphic Era deemed to be University, Dehradun, India.

Sakshi Painuli (S)

Department of Biotechnology, Graphic Era deemed to be University, Dehradun, India.

Kshipra Misra (K)

DRDO, DIPAS, Department of Biochemical Sciences, Timarpur, Delhi, India.

Navin Kumar (N)

Department of Biotechnology, Graphic Era deemed to be University, Dehradun, India.

Rakesh Kumar Bachheti (RK)

Department of Industrial Chemistry, College of Applied Science, Addis Ababa Science and Technology University, Addis Ababa, Ethiopia.
Department of Allied Sciences, Graphic Era Hill University (G.E.H.U), Society Area, Clement Town, Dehradun, 248002, India.

Nishant Rai (N)

Department of Biotechnology, Graphic Era deemed to be University, Dehradun, India.

Abdel Nasser B Singab (ANB)

Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo, Egypt.
Center of Drug Discovery Research and Development, Ain Shams University, Cairo, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH